Switch to Oral Antibiotics in Gram-negative Bacteremia

NACompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

October 13, 2019

Primary Completion Date

August 30, 2022

Study Completion Date

July 30, 2023

Conditions
Escherichia Coli BacteremiaKlebsiella BacteraemiaEnterobacter BacteraemiaSerratia BacteraemiaCitrobacter BacteraemiaProteus Bacteraemia
Interventions
OTHER

Step down to oral antimicrobial therapy

Step down from intravenous to oral antimicrobial therapy to complete the intended course of treatment.

OTHER

IV antimicrobial therapy

No step down from intravenous to oral antimicrobial therapy to complete the intended course of treatment.

Trial Locations (7)

Unknown

Bahrain Defense Forces Hospital, Manama

Farwaniya Hospital, Kuwait City

Hamad Medical Corporation, Doha

Istanbul Medipol University, Istanbul

Istanbul University Carrahpasa Medical School, Istanbul

Marmara University School of Medicine, Istanbul

Ordu University School of Medicine, Ordu

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY

NCT04146922 - Switch to Oral Antibiotics in Gram-negative Bacteremia | Biotech Hunter | Biotech Hunter